ABSTRACT. Insulin-degrading enzyme (IDE) was detected by immunoblot analysis in highly purified rat liver peroxisomes. IDE in the peroxisomal fraction was resistant to proteolysis by trypsin and chymotrypsin under conditions where the peroxisomal membranes remained intact. After sonication of the peroxisomal fraction, IDE was recovered in the supernatant fraction. Further, the localization of IDE in the peroxisomes was shown by immunoelectron microscopy. In addition, IDE isolated from peroxisomes degraded insulin as well as oxidized lysozyme as a model substrate for oxidized proteins. These results suggest that IDE exists in an active form in the matrix of rat liver peroxisomes and is involved in elimination of oxidized proteins in peroxisomes.
Insulin-degrading enzyme (IDE) is a nonlysosomal metalloendoprotease which is implicated in the degradation pathway of insulin in several cells (Duckworth, 1988) . In addition to its role in regulating insulin degradation, IDE appears to play an important role in the regulation of growth factor levels and cell differentiation (Becker and Roth, 1995; Authier et al., 1996b) . There is, in fact, increasing evidence that IDE binds and degrades transforming growth factor, atrial natriuretic peptide, insulin-like growth factors I and II (Garcia et al., 1989; Müller et al., 1992) . IDE is also suggested to regulate extracellular level of amyloid b-protein, accumulation of which is an early and necessary step in the pathogenesis of Alzheimer's disease (Qiu et al., 1998; Kurochkin and Goto, 1994) . Further, Fagan and Waxman have shown that IDE purified from rabbit erythrocytes degraded oxidatively damaged hemoglobin (Fagan and Waxman, 1991) . Therefore, IDE is a multifunctional protease in cellular regulation.
Recently, the primary structure of the IDEs from rat, human and Drosophila were elucidated by cDNA analysis and the IDEs were shown to contain carboxyl-terminal consensus sequence for peroxisomal targeting (Baumeister et al., 1993; Affholter et al., 1990; Kuo et al., 1990) . In contrast to other peroxisomal matrix proteins, a part of IDE was recovered in peroxisomal fraction (Authier et al., 1994) , but the majority was located mainly in the cytosolic fraction in many tissues and cell lines. Further, the existence of IDE in plasma membranes, lysosomes and endosomes has been suggested (Goldfine et al., 1984; Grisolia and Wallace, 1976; Hamel et al., 1991; Seta and Roth, 1997) . Therefore, the organelle localization of the IDE in cell is still controversial and it is not clear whether IDE exists inside of peroxisomes.
In this study, we have attempted to clarify the localization of IDE by a combination of immunoblot analysis, immunoelectron microscopy, and an insulin degrading assay and found that the IDE exists in an active form in the matrix of rat liver peroxisomes. In order to elucidate further the function of IDE in peroxisomes, we examined whether the IDE degrades oxidized proteins since some peroxisomal proteins seem to be easily oxidized by oxidative stress such as H2O2 produced in the organelle. (Nakamura and Goto, 1996) .
Materials and Methods

Materials
Preparation of peroxisomes and other organelles
Peroxisomes were prepared from rat livers by differential centrifugation in sucrose followed by isopycnic centrifugation in Nycodenz using the method of Imanaka et al. with some modifications (Imanaka et al., 1991) . About 0.5 ml of a light mitochondrial fraction was layered onto a 10 ml linear Nycodenz gradient (density span from 1.15-1.27 g/ml) in a RP 55VF rotor (Hitachi, Tokyo, Japan). The gradient rested on a 1.0 ml cushion of 1.30 g/ml Nycodenz. All Nycodenz solutions contained 0.25 M sucrose, 1 mM EDTA and 0.1% (v/v) ethanol. Centrifugation was carried out at 50,000 rpm (209,600´g) for 60 min at 4°C. Mitochondria were prepared by sucrose gradient centrifugation as described (Leighton et al., 1968) . Microsomes and cytosol were prepared by differential centrifugation according to the method of de Duve et al. (de Duve et al., 1955) . Lysosomes were prepared by Percoll density gradient centrifugation by the method of Arai et al. (Arai et al. 1991) .
Immunoelectron microscopy
Rat liver was perfusion-fixed with 4% paraformaldehyde, 0.25% glutaraldehyde, 0.01% CaCl2, and 0.15 M cacodylate buffer (pH 7.4) for 10 min at room temperature. Small liver tissue blocks were dehydrated and embedded in Lowicryl K4M at -20°C. Thin sections were cut with a diamond knife and mounted on nickel grids. Sections were incubated overnight with affinity purified anti-IDE antibody at 4°C. After washing with phosphate-buffered saline, sections were incubated with rabbit anti-mouse IgG for 30 min, followed by 30 min-incubation with protein A-gold (15 nm in diameter). After 10 min-fixation with 2% glutaraldehyde, sections were stained with uranyl acetate and lead citrate and examined with a Hitachi H7500 electron microscope.
Quantitative analysis of labeling density
The micrographs were taken at the magnification of 15,000-fold and enlarged to positive pictures at the final magnification of 30,000-fold. Areas of peroxisomes and cytoplasm including endoplasmic reticulum were estimated by use of a digitizer equipped with a computer (Gateway). Gold particles on each compartment were counted and labeling density in the compartments was calculated. The labeling density was expressed as gold particles per square micron of the compartments.
Assay of insulin and oxidized lysozyme degradation
Peroxisomes were disrupted with a Branson sonifier (Cell Disruptor 200; setting level, 5; 50% duty; 15 sec´3 times) at 0°C, and centrifuged at 200,000´g for 30 min. The supernatant was used for the enzyme assay. Insulin degrading activity was determined as described by Shii et al. with some modifications (Shii et al., 1985) . Briefly, peroxisomal fractions were incubated in 100 ml of reaction mixture containing 100 mM sodium phosphate (pH 7.5), 20 mg of bovine serum albumin and 160 nM [ 125 I] insulin. After incubation for 15 min at 37°C, 100 ml of cold 20% trichloroacetic acid was added. After standing for 15 min on ice, the samples were centrifuged at 10,000´g for 10 min in a microcentrifuge. Radioactivity in both the pellet and the supernatant was measured in a Gamma counter, ARC-300 (Aloka, Tokyo, Japan). Degradation activity of oxidized lysozyme was determined by release of trichloroacetic acid-soluble products from oxidized [ 125 I]lysozyme. Peroxisomal fraction was incubated with 1 mg of [ 125 I]lysozyme in 100 ml of reaction mixture containing 100 mM Tris/HCl (pH 8.0), 5 mM MgCl2, 1 mM dithiothreitol and 20 mg of bovine serum albumin for 30 min at 37°C. Radioactivity was measured as in insulin degrading assay. Since high concentration of Nycodenz inhibited the IDE activity against both the substrate, aliquots of samples from Nycodenz gradient centrifugation were dialyzed in 0.25 M sucrose containing 5 mM Hepes/KOH and 0.1 % (v/v) ethanol, pH 7.4 for 3 h at 4°C to remove Nycodenz before the enzyme assay was carried out.
Immunoprecipitation of IDE
Peroxisomes (1mg/ml) were treated with Triton X-100 (final concentration of 0.1%) for 30 min at 4°C. After centrifugation at 100,000´g for 30 min, the supernatant was incubated overnight with anti-IDE antibody at 4°C in phosphate-buffered saline. The immunocomplex was precipitated by the addition of protein GSepharose. After rotating for 60 min at room temperature, the fractions were centrifuged for 5 min at 10,000´g. The resulting supernatant was tested for the ability to degrade insulin and oxidized lysozyme as described above.
Other methods
Enzyme activities of catalase, N-acetyl-ß-D-glucosaminidase, cytochrome c oxidase, esterase and concentration of protein were assayed as described previously (Imanaka et al., 1991) . Immunoblotting was done as described (Small et al., 1988) . The quantitation of 
Results
Existence of IDE in peroxisomal fraction
Isolated subcellular fractions were subjected to immunoblot analysis using an anti-IDE monoclonal antibody. As shown in Fig. 1 , a polypeptide with an apparent molecular mass of 110 kDa was detected in the peroxisomal and cytosolic fractions. The molecular mass of the polypeptide was consistent with that of rat IDE (Authier et al., 1994; Shii et al., 1985) . The polypeptide was not detected in the mitochondrial, lysosomal and microsomal fractions.
The localization of IDE to peroxisomes was further investigated using Nycodenz gradient centrifugation. As shown in Fig. 2A , the peroxisomes, as marked by catalase, sedimented in fractions 10-12, and were well separated from other organelles such as mitochondria (cytochrome c oxidase), microsomes (esterase) and lysosomes (N-acetyl-ß- Fig. 1 . Demonstration of the existence of IDE in peroxisomal fraction by immunoblotting with anti-IDE antibody. Gel stained with Coomassie brilliant blue (lanes 1-5). Immunoblot analysis with anti-IDE antibody (lanes 6-10). Lanes 1 and 6, peroxisomes (Per); Lanes 2 and 7, mitochondria (Mit); Lanes 3 and 8, microsomes (Mic); Lanes 4 and 9, cytosol (Cyt); Lanes 5 and 10, lysosomes (Lys). Fifty µg of organelle or cytosol proteins were used for Coomassie brilliant blue staining and for immunoblotting. The broad band around 57 kDa in microsomal and lysosomal fractions seems to be a heavy chain of rat IgG since goat anti-mouse IgG slightly reacted with rat IgG. D-glucosaminidase). An equal volume of each fraction of the Nycodenz gradient was subjected to SDS-PAGE and the presence of IDE was investigated by immunoblotting (Fig.  2B) . The distribution profile of IDE in the Nycodenz gradient was similar to that of catalase. IDE was recovered in fractions 10-12 which correspond to catalase activity in peroxisomal particles. These results suggest that IDE exists in peroxisomes. In agreement with other reports (Alexson et al., 1985; Stamellos et al., 1992) , a portion of the catalase activity found in fractions 3 and 4, seems to be released from peroxisomal particles as a result of the peroxisomes being ruptured during the isolation procedure. A similar proportion of IDE polypeptide was also recovered in fractions 3 and 4.
The IDE exists in the matrix of peroxisomes
In order to determine whether IDE is located inside the peroxisomes, purified peroxisomes were treated with trypsin and chymotrypsin in the absence or presence of 0.2% (w/v) Triton X-100. As shown in Fig. 3 , in the absence of Triton X-100, proteolytic enzymes do not degrade known peroxisomal matrix proteins such as hydratase-dehydrogenase, acyl-CoA oxidase, catalase and urate oxidase, whereas 70 and 22 kDa peroxisomal integral membrane proteins were degraded (lane 2). However, in the presence of Triton X-100 several matrix proteins disappeared or were partially degraded (lane 3). Under these conditions, IDE polypeptide with the same molecular mass as intact IDE, was detected by immunoblotting in the absence of Triton X-100 and the amount of IDE was equal to that of intact IDE (lanes 4 vs 5). However, the band could not be seen when peroxisomal membranes were disrupted by Triton X-100 (lane 6). In a separate experiment, the band corresponding to IDE disappeared when the cytosolic fraction was treated with trypsin and chymotrypsin in the absence of Triton X-100 (data not shown). The result suggests that IDE itself is sensitive to digestion by trypsin and chymotrypsin.
After sonication of the peroxisomal fraction, about 90% of the IDE polypeptide was released from peroxisomal particles and recovered in the supernatant fraction (Fig. 4, lane  5) . In the same preparation almost all the matrix proteins were also recovered in the supernatant fraction, while peroxisomal integral membrane proteins, such as 70 and 22 kDa, were recovered in the particulate fraction (lanes 2 and 3). These results suggest that IDE is located in the matrix of peroxisomes. Fig. 5A shows immunoelectron micrographs of a rat liver section incubated with anti-IDE antibody, followed with anti-mouse IgG and protein A gold. The inside of the peroxisomes are intensely labeled with gold particles. The cytosol is also labeled, but at a substantially lower intensity than the peroxisomes. The concentration of IDE in peroxisomes is estimated to be ~3.5 times higher than that of cytosol ( Table  I) . As shown in Fig. 5B , few gold particles are present in peroxisomes and cytosol. These results also support the view that IDE is located in the matrix of peroxisomes.
Localization of IDE by immunoelectron microscopy
IDE activity against insulin and oxidized lysozyme
Insulin degrading activity was detected in the peroxisomal fraction and the activity showed a similar distribution to IDE polypeptide and catalase ( Fig. 2A) . The enzyme activity detected in highly purified peroxisomes was almost completely inhibited by NEM, bacitracin and EDTA (Table II) , all of which are well known inhibitors of IDE (Duckworth, 1988; Müller et al., 1992; Fagan and Waxman, 1991) . Inhibitors of serine and aspartic type proteases did not inhibit the insulin degrading activity. Oxidized lysozyme was also degraded to trichloroacetic acid-soluble products in peroxisomal fraction. The degrading activity to oxidized lysozyme was of the rate of ~2 mg/ hr/mg of peroxisomal proteins, did not depend on ATP, and was ~8 times higher than that to unoxidized lysozyme. Further, as shown in Table I the inhibition profile of oxidized lysozyme degradation by several inhibitors was very similar to that of insulin degradation. In addition, when immunoprecipitation was performed on the peroxisomal fraction with 10 µg of anti-IDE antibody, ~85% of insulin-degrading activity and ~80% of oxidized lysozyme-degrading activities were removed. In contrast, neither of the degrading activities was removed by incubation with the same amount of normal mouse IgG. These results suggest that IDE exists in an active form in the matrix of rat liver peroxisomes and is involved in the degradation of oxidized lysozymes.
Discussion
In this study, we have shown that IDE exists in rat liver peroxisomes by immunoblot and enzymic analysis and immunoelectron microscopy. Results from protease treatment and sonication of peroxisomes indicate that IDE is present in the matrix of peroxisomes (Figs. 3 and 4) . The existence of IDE in the peroxisomal fraction could not be explained by contamination from other organelles such as mitochondria, microsomes or lysosomes, since IDE co-sedimented with peroxisomes on Nycodenz gradient centrifugation and as well separated from the other organelles (Fig. 2) . Furthermore, the possibility that cytosolic IDE may have been adsorbed onto peroxisomes during their preparation is unlikely, since IDE in cytosol fraction was degraded by trypsin and even under conditions where the 70 and 22 kDa proteins, which are exposed on the cytosolic face of the peroxisomal membrane were degraded (Fig. 3) . Immunoelectron microscopic study also supports the view that IDE is located inside of peroxisomes (Fig. 5) .
A slight difference in the distribution among catalase activity, IDE protein and insulin degrading activity was observed on Nycodenz gradient (Fig. 2A) . We do not know the reason for this at present, but it might be explained by the heterogeneity of peroxisomes and the existence of some inhibitor (or activator ) against insulin degrading activity in peroxisomal fraction. A similar difference in the distribution was also shown in peroxisomal fraction (Authier et al., 1994) .
Previously, several investigators have suggested that the enzyme involved in the degradation of insulin may be locat- ed in the lysosomes, plasma membranes and endosomes (Goldfine et al., 1984; Grisolia and Wallace, 1976; Hamel et al., 1991) . However, we could detect no IDE polypeptide in highly purified lysosomal fraction, or in a microsomal fraction where endosomes and plasma membranes were enriched. We suggest that IDE is located only in the peroxisomes and cytosol in rat liver. In contrast to its almost total peroxisomal localization of hydratase-dehydrogenase and acyl-CoA oxidase, which also have a similar peroxisomal targeting motif (Yokota et al., 1987; Usuda et al., 1996) , a large amount of IDE is still located in cytosol. It has been calculated that peroxisomal and cytosolic proteins account for 2% and 35%, respectively, of the protein in fasted rat liver (Leighton et al, 1968; Fujiki et al., 1982) . Assuming that the concentration of IDE in peroxisomes is ~3.5 times higher than that of cytosolic fraction (Table I) , the amount of IDE in peroxisomes and cytosol is calculated to be ~20 % and ~80%, respectively. Separately we found the concentration of IDE in peroxisomal fraction was almost the same as that of IDE in cytosolic fractions by immunoblot analysis (Fig. 1) . It is well known that peroxisomes are fragile and that 35% or more of catalase is routinely liberated to the cytosolic fraction during homogenization (Amar-Costesec et al., 1974) . Assuming that about 35% of IDE is released from peroxisomes during homogenization, the amount of IDE in intact peroxisomes is calculated to be ~10%. Based on these calculations, we suggest that rat liver peroxisomes contain about 10-20% of total IDE. Recently it was shown that cytosolic IDE is associated with a 70 kDa cytosolic protein, interaction with which might decrease targeting efficiency of IDE into peroxisomes (Authier et al., 1996a) .
Concerning the function of peroxisomal IDE, it does not seem to be involved in the processing of insulin in rat liver peroxisomes. Recently Authier et al. have shown that IDE prepared from rat liver extracts degraded a cleaved leader peptide (peroxisomal targeting signal-2) of rat thiolase B precursor, although it did not cut out the leader peptide from the thiolase precursor (Authier et al., 1995) . Proteolytic activity of IDE might allow the degraded products of leader peptides to diffuse out of the peroxisomes.
Here we have shown the possibility that IDE degraded oxidized proteins in peroxisomes using oxidized lysozyme as a model substrate. We chose lysozyme as substrate by following reason. Lysozyme is widely used as substrate for proteases. It did not show any tendency toward aggregation in the metal-catalyzed oxidation system. Further, Kurochkin and Goto showed that a protease corresponding to IDE purified from rat liver cytosol fraction degraded oxidized lysozyme (meeting abstract, Kurochkin, I. and Goto, S. 1992. Biomed. Gerontol, 16: 108-109) . The above possibility was suggested by the following evidence. The oxidized lysozyme-degrading activity was inhibited by several compounds, all of which are well known inhibitors of IDE (Table II). The oxidized lysozyme and insulin degrading activities were removed from peroxisomal fraction by the immunoprecipitation of monoclonal antibody against IDE. We have also shown that peroxisomal IDE preferentially degraded oxidized lysozyme but not native lysozyme, and this fact is consistent with the results that IDE purified from rabbit erythrocytes degraded oxidatively damaged hemoglobin (Baumeister et al., 1993) .
A part of the peroxisomal proteins seems to be oxidized and damaged by continuous oxidative stress such as H 2 O 2 and O 2 -generated as the products of peroxisomal metabolism (Singh, 1996) . We could detect protein carbonyls in purified rat liver peroxisomes and the contents of protein carbonyls increased by clofibrate treatment in rats (data not shown). Taken together, we suggest that, as another function of IDE, IDE is involved in the degradation of oxidized proteins in the peroxisomes so as to control the quality of peroxisomal proteins. It would be interesting to test whether the contents of oxidized proteins decrease by overexpression of IDE in peroxisomes.
